Medizinisch-technischer Fortschritt im Gesund-heitswesen: Zentrale Kosten-Nutzen-Bewertung ohne Alternative? [PDF]
Arentz, Christine
core
Surrogate Endpoints for Overall Survival in Advanced Hepatocelluar Carcinoma in the Era of Immunotherapy: A Trial Level Meta-Analysis. [PDF]
Saleh Y +6 more
europepmc +1 more source
Herzinsuffizienz – IQWiG legt vorläufige Ergebnisse vor [PDF]
openaire +1 more source
Germany's Struggle with Prices for Patent-protected Drugs
Kifmann, Mathias, Neelsen, Sven
core
Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs. [PDF]
Kranz P, McGauran N, Ünal C, Kaiser T.
europepmc +1 more source
IQWiG bestätigt beträchtlichen Zusatznutzen für Edoxaban [PDF]
openaire +1 more source
Generating evidence that meets the requirements of both regulatory agencies and HTA bodies. [PDF]
Wieseler B, Preukschat D, Kranz P.
europepmc +1 more source
Navigating change: a comparative analysis of health technology assessment reforms across agencies - processes, drivers, and interdependencies. [PDF]
Kumar G +10 more
europepmc +1 more source
Weaning From Tobacco with Nicotine or Varenicline in Severe and Mild Tobacco Dependence—Findings of a Meta-Analysis. [PDF]
Selbach C +6 more
europepmc +1 more source
[IQWiG evidence report on psychological consequences of abortion]. [PDF]
Endres D, Gowik J, Tasar A.
europepmc +1 more source

